Ojemda Interactions
There are 400 drugs known to interact with Ojemda (tovorafenib). Of the total drug interactions, 119 are major, 269 are moderate, and 12 are minor.
Medications known to interact with Ojemda
Note: Showing generic names only.
A
- abciximab
- abemaciclib
- abiraterone
- acalabrutinib
- ado-trastuzumab emtansine
- albendazole
- alfentanil
- alpelisib
- alprazolam
- alteplase
- aminolevulinic acid
- aminolevulinic acid topical
- amiodarone
- amlodipine
- amprenavir
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- apremilast
- aprepitant
- ardeparin
- argatroban
- aripiprazole
- armodafinil
- ashwaganda
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- aspirin
- astemizole
- atazanavir
- atogepant
- atorvastatin
- avacopan
- avanafil
- avapritinib
- axitinib
B
- bedaquiline
- belumosudil
- bepridil
- betrixaban
- bexarotene
- binimetinib
- bivalirudin
- black cohosh
- boceprevir
- bortezomib
- bosutinib
- brentuximab
- brexpiprazole
- brigatinib
- bromfenac
- bromocriptine
- budesonide
- buprenorphine
- buspirone
- butorphanol
C
- cabazitaxel
- cabozantinib
- calaspargase pegol
- cangrelor
- cannabidiol
- capivasertib
- caplacizumab
- capmatinib
- carbamazepine
- cariprazine
- ceritinib
- cevimeline
- chlorotrianisene
- cilostazol
- citalopram
- clofarabine
- clomipramine
- clopidogrel
- cobicistat
- cobimetinib
- conjugated estrogens
- crizotinib
D
- dabigatran
- daclizumab
- dalteparin
- danaparoid
- daridorexant
- darifenacin
- darolutamide
- darunavir
- dasatinib
- deferasirox
- defibrotide
- delavirdine
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- dicumarol
- dienestrol topical
- diflunisal
- dihydroergotamine
- diltiazem
- dipyridamole
- docetaxel
- donepezil
- doravirine
- doxorubicin
- doxorubicin liposomal
- dronedarone
- drospirenone
- drotrecogin alfa
- duloxetine
- duvelisib
E
- edoxaban
- efavirenz
- elacestrant
- elagolix
- eliglustat
- encorafenib
- enfortumab vedotin
- enoxaparin
- entrectinib
- enzalutamide
- epirubicin
- epoprostenol
- eptifibatide
- ergonovine
- ergotamine
- erlotinib
- escitalopram
- esterified estrogens
- estradiol
- estradiol topical
- estrone
- estropipate
- estropipate topical
- eszopiclone
- ethinyl estradiol
- ethosuximide
- etodolac
- etonogestrel
- etoposide
- etranacogene dezaparvovec
- etravirine
- everolimus
- exemestane
F
- fedratinib
- felodipine
- fenfluramine
- fenofibrate
- fenoprofen
- fentanyl
- fidanacogene elaparvovec
- finerenone
- flibanserin
- fludrocortisone
- fluoxetine
- flurazepam
- flurbiprofen
- fluticasone
- fluvoxamine
- fondaparinux
- fosamprenavir
- fosaprepitant
G
H
I
- ibritumomab
- ibrutinib
- ibuprofen
- idelalisib
- iloprost
- imatinib
- indinavir
- indomethacin
- infigratinib
- inotersen
- interferon beta-1a
- interferon beta-1b
- iodine i 131 tositumomab
- iptacopan
- irinotecan
- irinotecan liposomal
- isavuconazonium
- isoniazid
- isradipine
- ivabradine
- ivacaftor
- ivosidenib
- ixabepilone
- ixazomib
K
L
- lapatinib
- larotrectinib
- lazertinib
- leflunomide
- lemborexant
- lenacapavir
- leniolisib
- lepirudin
- letermovir
- levamlodipine
- levobupivacaine
- levoketoconazole
- levomethadyl acetate
- levomilnacipran
- levonorgestrel
- lidocaine
- linagliptin
- lomitapide
- lonafarnib
- lumateperone
- lurasidone
M
- macitentan
- maraviroc
- maribavir
- meclofenamate
- medroxyprogesterone
- mefenamic acid
- mefloquine
- megestrol
- meloxicam
- methadone
- methotrexate
- methoxsalen
- methyl aminolevulinate topical
- methylergonovine
- methysergide maleate
- midazolam
- midostaurin
- mifepristone
- milnacipran
- mipomersen
- mirabegron
- mirtazapine
- mitapivat
- mobocertinib
- modafinil
- montelukast
N
- nabumetone
- naloxegol
- naltrexone
- naproxen
- nelfinavir
- nicardipine
- nifedipine
- nilotinib
- nimodipine
- nirogacestat
- nisoldipine
- nitisinone
- norethindrone
- norgestrel
O
- olaparib
- oliceridine
- olutasidenib
- omacetaxine
- omaveloxolone
- osilodrostat
- osimertinib
- oxaprozin
- oxycodone
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- palovarotene
- panobinostat
- paroxetine
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pemigatinib
- pentosan polysulfate sodium
- pentoxifylline
- perampanel
- pexidartinib
- phenobarbital
- phenylbutazone
- piroxicam
- pirtobrutinib
- plicamycin
- ponatinib
- porfimer
- pralsetinib
- prasugrel
- praziquantel
- progesterone
- progesterone topical
Q
R
- ramelteon
- ramucirumab
- ranolazine
- regorafenib
- relugolix
- remdesivir
- repaglinide
- repotrectinib
- resmetirom
- reteplase
- revumenib
- ribociclib
- rifampin
- rifapentine
- rilpivirine
- ripretinib
- ritlecitinib
- ritonavir
- rivaroxaban
- rolapitant
- ruxolitinib
- ruxolitinib topical
S
- saquinavir
- saxagliptin
- selpercatinib
- selumetinib
- sertraline
- sibutramine
- sildenafil
- silodosin
- sirolimus
- sirolimus protein-bound
- solifenacin
- sonidegib
- sorafenib
- sotorasib
- sparsentan
- streptokinase
- sulfinpyrazone
- sulindac
- sunitinib
- suvorexant
- suzetrigine
T
- tacrolimus
- tadalafil
- tamoxifen
- tasimelteon
- tazemetostat
- tecovirimat
- telaprevir
- telithromycin
- temsirolimus
- tenecteplase
- teriflunomide
- thioguanine
- thiotepa
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tolvaptan
- toremifene
- tositumomab
- trabectedin
- tramadol
- treprostinil
- trimethoprim
- tucatinib
U
V
- vadadustat
- valoctocogene roxaparvovec
- vemurafenib
- venetoclax
- venlafaxine
- verteporfin
- vilazodone
- vonoprazan
- vorapaxar
- vortioxetine
W
Z
Report options
QR code containing a link to this page
More about Ojemda (tovorafenib)
- Ojemda consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
